ENSC Earnings Ensysce Biosciences, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.52 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -3.98 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -3.42 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -2.04 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.39 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -11.45 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | -8.52 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -9.98 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | -8.21 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -70.40 | 2025-03-10 | 10-K |
| Q3 2024 | 2023-09-30 | -3.32 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -2.66 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -2.08 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | -139.42 | 2024-03-15 | 10-K |
| Q3 2023 | 2022-09-30 | -140.90 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -75.67 | 2023-08-11 | 10-Q |
| FY 2021 | 2021-12-31 | -1.48 | 2022-03-31 | 10-K |
| Q3 2021 | 2021-09-30 | -1.02 | 2021-11-15 | 10-Q |
| FY 2021 | 2020-12-31 | 0.00 | 2022-03-31 | 10-K |
| Q3 2021 | 2020-09-30 | -0.01 | 2021-11-15 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.